The ABL1 gene gives cells instructions for a signaling protein that helps control growth, movement, and repair after DNA damage. If this gene is changed in a way that switches it on at the wrong time, cells can grow and divide too much. A well-known example is when the ABL1 gene joins with the BCR gene, forming BCR-ABL1, which is closely linked to chronic myeloid leukemia and some acute lymphoblastic leukemias. Many people first hear about the ABL1 gene during leukemia testing because this discovery helped lead to targeted cancer medicines.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Other genes mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ABL1Gene function
What if the gene works
Your cells use the ABL1 gene to make a signaling protein that helps control growth, movement, and survival. It also supports responses to cell stress and helps keep the cell’s internal framework organized.
Risk
What if the gene does not work
Some variants in the ABL1 gene can cause heart and bone differences with growth or learning difficulties. Other changes in the ABL1 gene acquired later can cause leukemia. Effects can range from milder to more severe depending on the variant.
Treatment
What does that mean for your treatment
In BCR::ABL1-positive leukemia, treatment commonly uses tyrosine kinase inhibitors, medicines that block the ABL1 gene signal. Specific ABL1 variants can reduce response to some of these drugs and may guide a switch in treatment choice. For example, ABL1 T315I is linked to resistance to several earlier inhibitors, while ponatinib and asciminib can still be options.
Conditions associated with ABL1
Gene function
What if the gene works
Inside many cells, the ABL1 gene helps manage messages that tell a cell when to grow, move, or respond to strain. Its protein acts like a switch that turns other proteins on or off at the right time. Understanding what the ABL1 gene does in your body helps explain how cells keep daily activities organized.
The ABL1 gene helps cells pass along signals from their surface to inner control systems. This lets cells adjust their activity when they receive cues from nearby cells or from their environment.
Its protein helps control when cells grow, divide, and mature. This keeps everyday cell activity more organized and matched to the body’s needs.
The ABL1 gene helps manage parts of the cell’s inner framework, which gives cells shape and supports movement. This is important when cells attach, spread, or change position.
Inside the nucleus, the ABL1 gene helps cells respond to DNA damage and coordinate repair. Its protein works with your cells’ repair tools to support a more orderly response.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ABL1 gene can change how the ABL1 protein folds or how well its internal control regions keep signaling in check. In practice, how ABL1 gene variants affect protein function often comes down to altered kinase activity (its ability to add small phosphate tags that switch signals on). Some variants have a milder effect, while more disruptive variants can make the protein much more active or change how it interacts with other proteins. This range may influence how strongly ABL1-related features appear and when they begin.
How variants are linked to conditions
Acquired changes involving the ABL1 gene are best known for causing leukemia, especially the BCR::ABL1 fusion found in most chronic myeloid leukemia cases and some acute lymphoblastic leukemia. Rare inherited disease-causing variants in the ABL1 gene can also cause a genetic condition with congenital heart differences, short stature, and distinctive bone or facial features. This means ABL1 gene variants linked to leukemia and rare developmental conditions are clinically well established.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are commonly found across the general population. Most do not have a direct effect on health and simply reflect natural variation among people. For many genes, carrying a variant connected with a condition suggests a possible association rather than a definite diagnosis, especially when multiple genes and environmental influences contribute. Still, in some situations, one specific, well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or reduce health risks linked to the ABL1 gene. Anyone worried about personal or family risk can talk with a doctor or genetic counselor for advice based on their own health history.
Inheritance of ABL1 variants
For ABL1-related conditions, how ABL1 gene variants are inherited depends on whether the change is present in the body from birth or acquired only in blood cells. The well-established inherited pattern for germline ABL1-related developmental conditions is autosomal dominant, so a parent carrying the variant can pass it to each child with a 50% chance. Many affected people have a new (de novo) variant, which means it was not inherited from either parent. Changes in ABL1 found only in cancer cells are not passed from parent to child.
What does my ABL1 result mean for my family?
For the rare inherited condition linked to the ABL1 gene, the family pattern is usually dominant, so close relatives such as parents, brothers, sisters, and children may also carry the variant and may want to consider testing. In some families, the variant happens for the first time in one person and is not found in either parent. The meaning for relatives depends on whether your result is this rare inherited ABL1 finding or an acquired change found only in cancer cells.
Genetic information
Genetic testing
How you find out about variants
ABL1 genetic testing for variants usually uses a blood or saliva sample to read the DNA in the ABL1 gene. If cancer is being evaluated, testing may use blood or bone marrow to look for acquired ABL1 changes. Results show whether a variant was found, but they do not always predict symptoms on their own.
When should I consider getting a genetic test?
Testing for changes involving the ABL1 gene is usually considered when a blood cancer such as chronic myeloid leukemia or some acute leukemias is suspected or already diagnosed, because it can confirm the diagnosis and help guide treatment. In some families, testing may also be discussed for a rare inherited condition linked to ABL1.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains depends on the condition and the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other aspects of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how people respond to medicines. Two people can take the same drug at the same dose and have different results because their bodies may absorb, break down, transport, or respond to that medicine in different ways. These inherited differences are common and can affect how well a treatment works or how sensitive someone is to side effects. This is one reason medication response is often more individual than it first appears.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. By looking at the relationship between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the ABL1 gene
When should I seek medical advice?
There isn’t yet a broadly confirmed role for this gene in routine inherited drug-response care, so general questions about medicines or side effects are best discussed with your doctor. In cancer care, ABL1 changes in leukemia cells, especially the BCR-ABL1 gene fusion, can help guide the use of targeted treatments.
History
The ABL1 gene became historically important through research on chronic myeloid leukemia, a blood cancer that helped change cancer genetics. In 1960, doctors identified an unusually small chromosome in leukemia cells, later named the Philadelphia chromosome. Building on this early work, scientists uncovered more about the gene when they showed in the 1980s that the ABL1 gene had moved next to another gene, creating the BCR-ABL1 fusion. That discovery helped confirm that specific gene changes can drive cancer. It also opened the door to targeted treatment, with medicines designed around this finding becoming a major milestone in modern cancer care. Because of this history, ABL1 remains one of the best known genes in the story of precision medicine.